Integra LifeSciences Holdings Corporation (IART)
Nasdaq: IART · Surgical & Medical Instruments & Apparatus · Princeton, NJ · filing with the SEC since 1996
Grade4.9
◀ Past 7.0● Present 4.4▶ Future 3.5
Who owns Integra LifeSciences Holdings Corporation
As filed with the SECHolders of 5% or more
3
Blackrock, Inc. holds 13.2% of Common Stock, as its SCHEDULE 13G/A filed Jul 17, 2025 says.
Directors and officers
16
report now, of 35 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 17, 2025 · Common Stock
Rubric Capital Management LP
SCHEDULE 13G/A · filed Jul 9, 2025 · Common Stock, par value $0.01 per share · 6.01% in May 14, 2025
Vanguard Portfolio Management
SCHEDULE 13G · filed Jul 31, 2026 · Common Stock
Fuller & Thaler Asset Management, Inc.
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock · reported falling below 5%
Invesco LTD
SCHEDULE 13G/A · filed Nov 6, 2025 · Common Stock · reported falling below 5%, from 5.3% in May 9, 2025
Morgan Stanley
SCHEDULE 13G/A · filed Aug 5, 2025 · Common Stock · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
Paradigm Capital Management Inc/ny
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock · reported falling below 5%, from 5.2% in May 15, 2026
What IART reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Acclarent, Inc.
A company bought · acquisition · Mar 2024 · owns, named in the 10-K filed Feb 26, 2026
Arkis BioSciences Inc.
A company bought · acquisition · owns, named in the 10-K filed Feb 26, 2026
Derma Sciences
A company bought · acquisition · owns, named in the 10-K filed Feb 26, 2026
Surgical Innovation Associates Inc
A company bought · acquisition · owns, named in the 10-K filed Feb 26, 2026
93 subsidiaries in 28 countries, from the list filed with the 10-K filed Feb 26, 2026.
Insider tradesForm 4
0sales
1purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 36 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Graves Jeffrey A | director | 0 | $0 | 0 | 1 | $100,000 |